ENPH Bears Trim as Stock Bounces, But Position Remains Heavy

Enphase Energy staged its sharpest single-day rally in weeks on November 3, gaining nearly 9%, yet the short base that rebuilt aggressively after the October 27 earnings miss has barely budged, leaving the stock in a genuinely unusual position: a significant bounce with 22.6% of the free float still held short.

Short interest has edged down from its post-earnings peak but remains elevated. At 29.5 million shares, SI stands at 22.6% of the float, down less than 1% on the day and up 1.7% on the week. The monthly picture is more striking: short interest has risen 21.7% over the past 30 days, as bears rebuilt aggressively after the Q3 miss and weak Q4 guide. Days to cover from the FINRA fortnightly settlement is 6.27. The ORTEX short score is 65.2, its highest reading of the past two weeks, so despite Tuesday's bounce, bear conviction has not retreated materially. What has changed is the lending market. Availability has tightened to 301%, down from 397% a week ago and from above 430% in late October. Shorts still face no meaningful friction, cost to borrow is just 0.45%, but the pool is narrowing. Options positioning has shifted in the other direction: the put/call ratio has dropped to 0.62, more than a standard deviation below its 20-day average of 0.65, its lowest reading of the past year. After weeks of defensive hedging, options traders rotated toward calls on the bounce.

The Street broadly cut targets in the wake of Q3 results but held ratings, a classic pattern of selective capitulation rather than wholesale abandonment. Goldman Sachs reduced its target from $47 to $40 while keeping its Buy rating. JP Morgan trimmed from $35 to $29 at Neutral. Barclays cut sharply, from $44 to $26, maintaining Equal-Weight. Citigroup moved last, lowering to $25 from $37 while staying Neutral. Oppenheimer was the exception, downgrading outright to Perform. The consensus mean target is $40.58, well above the current price of $30.42, but that figure includes targets set before the results were fully digested. At current levels, valuation multiples have expanded mechanically: the PE has risen 8.5 points over the week to 20.7x, and EV/EBITDA has moved up more than six turns to 17.1x, both reflecting the compressed earnings base rather than any recovery in fundamentals. The EPS surprise factor score sits at the 14th percentile, and EPS momentum over both 30 and 90 days ranks in the bottom decile of the universe.

The bear case is concrete and near-term: Q3 revenue of $293.3 million and adjusted EPS of $0.41 missed on both lines, with underlying demand running roughly $30 million below plan. The Q4 guide of $225 million to $255 million implies sequential deterioration, with battery shipments guided to just 100 to 120 MWh against the Q3 figure of around 450 MWh. Free cash flow turned negative at $11.4 million. The bull case rests on a longer runway: best-in-class microinverter margins, a battery ramp toward 675 MWh in 2027, commercial revenue expected to exceed $100 million next year, and early-stage optionality from the SST platform with more than 50 customers in the pipeline. The gap between those two frames is wide, and Tuesday's bounce has not resolved it.

The most newsworthy data point this week sits in the insider register. CEO Badrinarayanan Kothandaraman bought 10,000 shares at $26.75 on November 2, an open-market purchase worth $267,514, with no 10b5-1 plan attached. Director Shanker Trivedi followed with a 1,000-share purchase at $30.59 on November 3. Neither trade is large relative to the company's $4 billion market cap, but both are discretionary and both came within days of each other at multi-year lows for the stock. The 90-day insider net across all trades is positive at 9,500 shares, almost entirely driven by this pair of open-market buys. BlackRock remains the dominant institutional holder at 17.7% of shares, and added 1.25 million shares in its most recent filing through September 30.

ORTEX's Wikipedia and ORTEX page-view data registered a retail attention z-score of 2.84 as of October 28, well above the name's own 90-day history. That spike aligns with the earnings-day selloff and the subsequent coverage wave, so it reflects reaction rather than anticipation.

The next earnings event is scheduled for February 3, 2027. Between now and then, the question is whether the gap between insider buying conviction and short-seller positioning narrows, and whether the Q4 print in February lands within or below the already-reduced guide range.